4,022 projects

Date from new to old

NYSKAPNING-NYSKAPNING

CD38 Therapies in ME/CFS and Long COVID

...

Awarded: NOK 0.50 mill.

Project Period: 2025-2026

Location: Vestland

HELSEFORSKNING-Helseforskning

Building an ex vivo tumor microenvironment platform for development of combination therapies and drug resistance studies in head neck cancer

Head and neck squamous cell carcinoma (HNSCC) ranks among the top ten most prevalent cancers globally. Despite aggressive multimodal treatments, patient survival has seen minimal improvement over recent decades, with recurrence rates of 40-60%. The repertoire of approved molecular drugs for HNSCC...

Awarded: NOK 3.5 mill.

Project Period: 2025-2028

Location: Vestland

NYSKAPNING-NYSKAPNING

A Biomarker-Based Tool for Early Diagnosis and Monitoring of Lupus Nephritis

A Novel Diagnostic Tool for Early Detection and Monitoring of Lupus Nephritis (LN). Research from Oslo University Hospital, initiated in 2019, has led to the development of an innovative diagnostic tool for lupus nephritis (LN). The tool, based on a biomarker, has progressed from preclinical stu...

Awarded: NOK 0.50 mill.

Project Period: 2025-2026

Location: Oslo

FOFORMIDLING-FOFORMIDLING

SOS – Folk i beredskap

"SOS – Folk i beredskap" vil omhandle temaet trygghet på ulike fagområder, i samarbeid med Direktoratet for samfunnsforskning og beredskap (DSB), Nasjonal sikkerhetsmyndighet, Norges geologiske undersøkelse (NGU) og NTNU. Målgruppe: 300 voksne. Vi planlegger et tverrfaglig foredragsprogram: • DSB...

Awarded: NOK 35,000

Project Period: 2025-2025

Location: Trøndelag - Trööndelage

FOFORMIDLING-FOFORMIDLING

Mentalt yteevne: Robusthet og trygghet i en usikker tid

"Mentalt yteevne: Robusthet og trygghet i en usikker tid" er et forskningsbasert arrangement for VG3-elever i Lillehammer, som gir innsikt i hvordan prestasjons- og idrettspsykologi kan styrke mental robusthet og trygghetsfølelse i ulike livssituasjoner. Gjennom en kombinasjon av teori og praksis...

Awarded: NOK 50,000

Project Period: 2025-2025

Location: Innlandet

FOFORMIDLING-FOFORMIDLING

Forskningstorg om kropp og sinn

Forskningsmiljøer fra flere helserelaterte institusjoner ved UiO samarbeider om å gi publikum en engasjerende dag med kunnskap og aktiviteter om kropp og sinn gjennom å lage og bemanne boder med forskjellige forskningsaktiviteter. Kunnskap om hva som gir god helse og bærekraftig behandling av u...

Awarded: NOK 40,000

Project Period: 2025-2025

Location: Oslo

REKRUTTERING-REKRUTTERING

Bruk av helsedata for å understøtte arbeid med prioriteringer for å sikre bærekraft i helsetjenesten – en studie av byrden av MS i Norge

MS in Norway: How Does the Disease Affect Patients – and Society? Multiple sclerosis (MS) is a serious and chronic neurological disease that affects thousands of Norwegians. Today, more than 12,000 people in Norway live with MS, yet we still know too little about how the disease actually impacts ...

Awarded: NOK 2.2 mill.

Project Period: 2025-2028

Location: Oslo

NYSKAPNING-NYSKAPNING

Novel therapeutic strategies for pancreatic cancer

The project aims to develop innovative treatments for pancreatic cancer, one of the deadliest types of cancer with very low survival rates, especially for patients with advanced disease. The focus is on creating and testing new drugs that can be used on their own or in combination with existing t...

Awarded: NOK 0.50 mill.

Project Period: 2025-2026

Location: Oslo

FRIPROSJEKT-FRIPROSJEKT

Cytotoxic activity of NK cell-derived extracellular vesicles against cancer cells.

Our immune defence provides us a natural defence against cancer. Natural Killer (NK) cells is part of our immune system, and are specialized on seeking out and killing cancer cells. Cancer cells can avoid detection by the immune defence, and when this happenes the cancer cells can form a lump (tu...

Awarded: NOK 12.0 mill.

Project Period: 2025-2029

Location: Oslo

FRIPROSJEKT-FRIPROSJEKT

Disrupting Neuropilin-2 mediated Immunosuppression: A New Frontier in Cancer Immunoediting

Our immune system constantly scans the body for external threats like viruses or internal threats like abnormal cells that can become cancerous. But here’s the twist: sometimes, the immune system doesn’t just fight cancer — it can also unintentionally help it grow. Scientists call this complex re...

Awarded: NOK 4.8 mill.

Project Period: 2025-2028

Location: Vestland

HELSEFORSKNING-Helseforskning

Mechanisms of resilience and vulnerability to environmental challenges in mental health

Childhood adversities can have a profound impact on mental health, extending far into adulthood. These early challenges, such as trauma or neglect, can increase the likelihood of experiencing mood disorders or anxiety later in life. However, the story isn't the same for everyone. While some indiv...

Awarded: NOK 3.3 mill.

Project Period: 2025-2028

Location: Oslo

FOFORMIDLING-FOFORMIDLING

Når tryggheten til kroppen og framtida forsvinner - Hvordan kan vi forstå og behandle «long COVID» og CFS/ME?

Langvarig utmattelse og andre kroniske uforklarte lidelser frarøver de rammede tryggheten til at kroppen fungerer som forventet for å kunne håndtere livets krav. Tryggheten for å kunne fullføre utdanning og få en yrkeskarriere delta i sosiale aktiviteter, og etablere nære relasjoner og en familie...

Awarded: NOK 40,000

Project Period: 2025-2025

Location: Møre og Romsdal

FRIPROSJEKT-FRIPROSJEKT

When breast cancer hits a nerve - Neural involvement as a hallmark of tumor progression

The aim of this project is to investigate nerve involvement in primary breast cancer and brain metastatic breast cancer. Our hypothesis is that a subset of aggressive breast cancers engages the nervous system to drive tumor progression, including metastases to the brain tissue, the most neurogeni...

Awarded: NOK 12.0 mill.

Project Period: 2025-2029

Location: Vestland

NYSKAPNING-NYSKAPNING

Gd-BioP - a gadolinium based biocompatible contrast agent for MRI

...

Awarded: NOK 0.50 mill.

Project Period: 2025-2026

Location: Trøndelag - Trööndelage

HELSEFORSKNING-Helseforskning

Development Of Patient-derived organoid PLatforms for Evading Resistances in Lung Cancer

Lung cancer remains the leading cause of cancer death globally. Despite advancements in targeted therapies for oncogene drivers like EGFR and KRAS mutations, both intrinsic and acquired resistance ultimately limit their effectiveness. While in vitro studies using 2D cultures have identified resis...

Awarded: NOK 3.5 mill.

Project Period: 2025-2028

Location: Trøndelag - Trööndelage

HELSEFORSKNING-Helseforskning

Human avatar on chip for advancing personalized cancer therapies by integrating vascular and immune components in a Tumor-on-Chip model

Background/rationale: Despite advances in breast cancer therapies, certain tumors remain lethal due to their ability to evade immune system attacks. This immune evasion is strongly influenced by the tumor microenvironment (TME), which includes tumor endothelial cells (TECs), immune cells, and ca...

Awarded: NOK 3.5 mill.

Project Period: 2025-2028

Location: Oslo

FOFORMIDLING-FOFORMIDLING

Researchers' Night: Pust som medisin – for bedre helse, trening og trygghet

'Researchers' Night: Pust som medisin – for bedre helse, trening og trygghet' er et formidlingsarrangement under Forskningsdagene i Bergen og arrangeres 26. september på et lokale i Bergen sentrum. Arrangementet er et samarbeid mellom aktørene i Alrek helseklynge og Forskningsdagene i Bergen. Ar...

Awarded: NOK 60,000

Project Period: 2025-2025

Location: Vestland

REKRUTTERING-REKRUTTERING

Clinical predictors of treatment response in dry eye disease

Dry eye disease is a multifactorial inflammatory disease characterized by an unstable tear film, most often due to decreased quality of the outer lipid layer produced by modified sebaceous glands in the eyelids. Due to the many different underlying causes of dry eye disease, several treatments an...

Awarded: NOK 2.2 mill.

Project Period: 2025-2029

Location: Oslo

PESORDNING-PESORDNING

Preparedness using Artificial Intelligence for rapid vaccine design

The project proposes the development of a rapid-response vaccine design and manufacturing pipeline powered by AI to address future pandemic threats. Leveraging recent advances in machine learning, we aim to accelerate the generation of broadly protective vaccines fully aligned with the “100 days”...

Awarded: NOK 69,999

Project Period: 2025-2025

Location: Oslo

NYSKAPNING-NYSKAPNING

Novel drug candidates for treating heart failure and cardiac fibrosis

Heart failure affects millions of people and is a leading cause of both death and hospital admissions. For patients with heart failure with preserved ejection fraction (HFpEF), there are currently few effective treatment options. A central disease mechanism is fibrosis, which is scar formation in...

Awarded: NOK 5.0 mill.

Project Period: 2025-2026

Location: Oslo

REKRUTTERING-REKRUTTERING

Development of a novel targeted radionuclide therapeutic for haematological malignancies

Although great strides have been made in cancer treatment, there is still a strong need for better therapies for blood cancers such as lymphoma and leukemia. This project aims to meet that need by developing a new type of treatment called Targeted Radionuclide Therapy (TRT). TRT uses tiny amounts...

Awarded: NOK 2.2 mill.

Project Period: 2025-2029

Location: Oslo

REKRUTTERING-REKRUTTERING

PreDXClearance: A novel biomarker system to predict ARIA/CAA and personalised therapy in Alzheimers disease

Alzheimer’s disease(AD) is one of the most devastating brain disorders, causing memory deterioration and thinking abilities. Although it is not fully understand what causes it, one of the most prominent theories suggests that a sticky protein called amyloid-beta (Aß) builds up in the brain and t...

Awarded: NOK 2.2 mill.

Project Period: 2025-2028

Location: Oslo

REKRUTTERING-REKRUTTERING

Rationally designed TET2 activators to target BRCA1 wild-type Triple-Negative Breast Cancer.

Triple-Negative Breast Cancer (TNBC) is one of the most aggressive and difficult-to-treat forms of breast cancer. Unlike other types of breast cancer, TNBC lacks the three receptors (estrogen, progesterone, and HER2) that are typically targeted by current therapies. As a result, patients with TNB...

Awarded: NOK 2.2 mill.

Project Period: 2025-2028

Location: Oslo

REKRUTTERING-REKRUTTERING

Uønskede hendelser i helse- og omsorgstjenestene: en kvalitativ studie av kommunenes og tilsynsmyndighetenes undersøkelser og oppfølging

Patient injuries resulting from adverse events are a persistent problem in health and care services, both in Norway and internationally. Research shows that around 10 percent of patients admitted to hospitals are harmed by the treatment they receive, and that about half of these injuries could ha...

Awarded: NOK 2.2 mill.

Project Period: 2025-2029

Location: Oslo

HELSEFORSKNING-Helseforskning

SAMFUNNSOPPDRAG: Inkludering av barn og unge i risikosone

Arrangementet forventes å ha tydelig mål og nytteverdi for deltakerene. Det intieres og gjennomføres av Eitri innovasjonssenter, som er et samarbeidsinitiativ mellom Universitetet i Bergen og Helse Bergen, og er en del av VIS (Vestlandets innovasjonsselskap AS). Senteret ble etablert som en broby...

Awarded: NOK 0.15 mill.

Project Period: 2025-2025

Location: Vestland

HELSEFORSKNING-Helseforskning

Does Universal Basic Income improve health? Existing Knowledge, Knowledge Gaps and the design of a Randomised Controlled Trial.

Good health and productivity are associated. The relationship has benefitted society through greater years lived without disability and longer working lives. However, increasing numbers are leaving the workforce to claim disability benefit, with the largest increases at each end of the age distri...

Awarded: NOK 71,615

Project Period: 2025-2025

Location: Oslo

NYSKAPNING-NYSKAPNING

Verifying the therapeutic potential of newly discovered siRNA drug candidates for treating acute leukemia.

...

Awarded: NOK 0.50 mill.

Project Period: 2025-2025

Location: Trøndelag - Trööndelage

NYSKAPNING-NYSKAPNING

ORION - Optimized ultRasound lesION imaging

Awarded: NOK 5.0 mill.

Project Period: 2025-2028

Location: Trøndelag - Trööndelage

NYSKAPNING-NYSKAPNING

Evidence-Based Lesion Recognition App for Diagnosing Female Genital Schistosomiasis

The @IR-FGS project is developing a mobile app to help diagnose and improve training for a neglected tropical disease called Female Genital Schistosomiasis (FGS). This disease affects more than 56 million women and girls, mainly in sub-Saharan Africa. Because its symptoms are similar to those of ...

Awarded: NOK 0.50 mill.

Project Period: 2025-2026

Location: Agder

NYSKAPNING-NYSKAPNING

TwinTarget ALS: Targeting microglia and as mast cells to revolutionise ALS Treatment

...

Awarded: NOK 0.50 mill.

Project Period: 2025-2026

Location: Trøndelag - Trööndelage

1 2 3 4 5 135